Read this company snapshot
Daily valuation snapshot
Fresenius Medical Care AG: source evidence dated 2026-10-09.
- Daily close (USD)
- $21.06
- Market capitalization (USD)
- $10,329,494,731.92
- Price / earnings (TTM)
- 7.67
- Price / book
- 0.62
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research FMS in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research FMS in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing FMS with another company.
| Daily close (USD) | $21.06 |
| Market capitalization (USD) | $10,329,494,731.92 |
| Price / earnings (TTM) | 7.67 |
| Price / book | 0.62 |
No matching rows. Clear the filter to see all records.
Read FMS's valuation metrics
Company size
Fresenius Medical Care AG's recorded market capitalization is $10,329,494,731.92. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
FMS's recorded P/E is 7.67: about $7.67 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
FMS's recorded price-to-book ratio is 0.62. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Fresenius Medical Care AG with Aurora
Use the snapshot above to ask a specific question about FMS. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow FMS's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.